SOPHiA GENETICS (SOPH) Non-Current Deferred Tax Liability (2020 - 2021)
SOPHiA GENETICS's (SOPH) quarterly Non-Current Deferred Tax Liability came in at $646000.0 in Q4 2021, up 101.25% year-over-year from $321000.0 in Q4 2020, and up 101.25% quarter-over-quarter from $321000.0 in Q4 2020.
Powered by 
Analysis
SOPHiA GENETICS (SOPH) Non-Current Deferred Tax Liability (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $646000.0 for Q4 2021.
- In Q4 2021, Non-Current Deferred Tax Liability rose 101.25% year-over-year to $646000.0; the TTM figure through Dec 2021 stood at $646000.0 (up 101.25% YoY), while the FY2021 annual figure was $646000.0, up 101.25% from the prior year.
- Non-Current Deferred Tax Liability came in at $646000.0 for Q4 2021 at SOPHiA GENETICS, up from $321000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $646000.0 in Q4 2021 to a low of $321000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn |
| 10 | SOPHiA GENETICS | 554.05 Mn | 446.39 Mn | 15.06 Mn |